A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
about
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockTemporary mechanical circulatory support: a review of the options, indications, and outcomesPercutaneous Ventricular Assist Devices: A Novel Approach in the Management of Patients With Acute Cardiogenic ShockCurrent state-of-the-art of device therapy for advanced heart failureA team-based approach to patients in cardiogenic shock.Trends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012.A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention.Short- and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support.How much of the intraaortic balloon volume is displaced toward the coronary circulation?Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery.Interprovincial spoke-to-hub transport using the Impella Recover LP 5.0 left ventricular assist device as a bridge to long-term circulatory support.Mechanical circulatory support in acute cardiogenic shockThe current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella RegistryMechanical circulatory support in cardiogenic shock - what every interventional cardiologist should know.Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.Successful use of the Impella device in giant cell myocarditis as a bridge to permanent left ventricular mechanical support.Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMODoubling survival and improving clinical outcomes using a left ventricular assist device instead of chest compressions for resuscitation after prolonged cardiac arrest: a large animal study.Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure.Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction.Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to takotsubo cardiomyopathy.Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella CathetersA novel method for percutaneous insertion of a right ventricular assist device.Use of a Vascular Sheath in the Axillary Artery as an Alternative Access Approach for Placing an Impella 5.0 Device.Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary RevascularizationIntra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of StabilizationUse of Mechanical Circulatory Support in Percutaneous Coronary Intervention in the United States.Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysiseComment. The use of mechanical assistance devices in post-infarction ventricular septal defects.Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrestPercutaneous left ventricular assist device in high risk percutaneous coronary intervention.Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial InfarctionShort-term mechanical unloading with left ventricular assist devices after acute myocardial infarction conserves calcium cycling and improves heart function.Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.The effectiveness of extracorporeal membrane oxygenation in a patient with post myocardial infarct ventricular septal defect.Integration of medical therapy and mechanical circulatory support in the management of acute heart failureMechanical circulatory support in the ICCU.Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.Out-of-hospital cardiac arrest -optimal management.Diagnosis and management of acute heart failure
P2860
Q24235462-C035B2CF-2C0A-4366-8DA5-7BD573A98710Q26824537-B57E9A78-0A46-4DCF-88E8-09C62FA91DB9Q28079983-ED34A8BA-1A0E-4B33-9648-B4CFBE9A8813Q28081412-A04DFFC9-C9DB-4932-AB08-EF4C86E5200CQ30252059-C63AD93E-25BE-4AF1-A5CF-B73C32DAB8BBQ30919406-2D58E617-52EC-4E03-B339-950C1CDC84B2Q33652803-17DD0B3C-C08B-4772-95FA-7D9CE23AF991Q33674241-7CDA8923-5C69-4559-ADA9-6417A28D611BQ33939944-1536582F-FF8B-43F7-9F01-28363656C9AEQ34172370-A7762CC2-4E1E-4AC1-ADBE-8E138DB2F3D0Q34196747-5FE9CEFA-CEDA-4E6C-A54E-3816E9378A48Q34312460-D8DE38BA-18C0-4D64-9515-BE9A61D19D6BQ34548705-EF33E793-4295-4980-A0A5-D3EB51E781F2Q34613403-4DEA919C-CEFA-49CE-AE08-3E4047EF2565Q34716730-9E7D4234-5205-4C01-95FD-10790F08A604Q35138284-ADC542FD-C96E-4418-8D22-B8F138773FDCQ35210117-9E8FAA5E-835F-4340-8115-91DCA35C08ECQ35530227-600E208B-2E84-47FE-B5E7-91E142792453Q35545474-0351733A-F597-4379-BA37-48D876814B87Q35559149-65072073-CD25-490A-9BB1-B39BB0A98D50Q35614597-BECE945F-21D4-48F0-A111-A800B7C46341Q35756621-97F4DB0D-A407-4E0A-91AF-062C5E86F6F0Q36019435-18AA4087-6A17-49D8-85BE-309C9D31DC5CQ36052039-E2761046-5BDF-4796-82ED-16FB4E3641D3Q36092564-5D2E20B3-E234-43CE-A2F9-8878D5186F51Q36240491-7E9AE5EB-8D8D-432F-B30C-DD6CEFA23678Q36403148-65B3CE41-2465-4FCC-9F14-72DC60801E89Q36505924-F4EE46EF-CDE1-4470-B3B5-A06511E4843FQ36543993-EB82EE67-CD94-4961-A72E-2906913D3EFCQ36627565-5D03CE5C-56D1-4A11-8079-A85835CC71B6Q36724085-DCB0AB86-7518-4A0F-91D1-FB8D112C8065Q36848829-0EDB56A2-6BFF-4A0B-BE8F-6490A789623CQ37119735-C3DB0AD2-EBD1-4640-9179-33DCA2C45402Q37162562-944C8DD0-D0B0-4556-A04C-CB535C266250Q37286089-F41C5831-D651-476D-BD9F-98351FAA25EFQ37412632-EC5385D3-C81D-411F-8599-03FCDC65F3EFQ37594626-27D535D6-402B-4936-8B4D-AE261C560FB5Q37595004-AEC47F7E-C7C4-45D6-9A5D-BD272DA2802CQ37614912-B1EFC314-EDCE-4B68-988E-5FF2B65559B4Q37680530-FA9DB83D-FC04-4ABD-AB78-DEBBB1E96A29
P2860
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A randomized clinical trial to ...... used by myocardial infarction.
@ast
A randomized clinical trial to ...... used by myocardial infarction.
@en
A randomized clinical trial to ...... used by myocardial infarction.
@nl
type
label
A randomized clinical trial to ...... used by myocardial infarction.
@ast
A randomized clinical trial to ...... used by myocardial infarction.
@en
A randomized clinical trial to ...... used by myocardial infarction.
@nl
prefLabel
A randomized clinical trial to ...... used by myocardial infarction.
@ast
A randomized clinical trial to ...... used by myocardial infarction.
@en
A randomized clinical trial to ...... used by myocardial infarction.
@nl
P2093
P50
P921
P1476
A randomized clinical trial to ...... used by myocardial infarction.
@en
P2093
Dirk Sibbing
Georg Fröhlich
Iris Bauer
Josef Dirschinger
Melchior Seyfarth
Robert Byrne
P304
P356
10.1016/J.JACC.2008.05.065
P407
P577
2008-11-01T00:00:00Z